Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.34 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22371828 | 1.00 | PDK1 (0.34) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL22694798 | 1.00 | PDK1 (0.34) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL28984601 | 0.97 | — | — | |
| SCHEMBL1545093 | 0.83 | — | — | |
| SCHEMBL17885864 | 0.81 | PDK1 (0.34) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL1034374 | 0.81 | PDK1 (0.34) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL20434835 | 0.79 | PDK1 (0.33) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL17885866 | 0.78 | PDK1 (0.31) | PDK1PDK2PDK3PDK4 | |
| SCHEMBL6114283 | 0.78 | — | — | |
| SCHEMBL8518512 | 0.77 | PDK1 (0.36) | PDK1PDK2PDK3PDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993018748-A1 | COMPOSITIONS COMPRISING A DRUG DELIVERY VEHICLE SUSPENDED IN A NONAQUEOUS FLUORINATED LIQUID | ALLERGAN, INC. (US) | 1993-09-30 | — | — | WO | claimed |
| CN-118956350-A | Refrigerant compositions comprising HFC-32, CF3I and CO2 | 科慕埃弗西有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-114364767-B | Refrigerant compositions comprising HFC-32, CF31 and CO2 | 科慕埃弗西有限公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-113518815-B | Heat transfer compositions comprising R-1225ye (E) | 科慕埃弗西有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-7235227-B2 | Paramagnetic particles that provide improved relaxivity | BARNES-JEWISH HOSPITAL (US) | 2007-06-26 | — | — | US | disclosed |
| EP-1487334-A4 | PARAMAGNETIC PARTICLES THAT PROVIDE IMPROVED RELAXIVITY | BARNES JEWISH HOSPITAL (US) | 2006-10-25 | — | — | EP | disclosed |
| WO-2006083269-A2 | LUMINESCENT NANOSENSORS | FLORIDA ATLANTIC UNIVERSITY (US) | 2006-08-10 | — | — | WO | disclosed |
| WO-2005097208-A2 | TISSUE OXYGENATION MEASUREMENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2005-10-20 | — | — | WO | disclosed |
| US-6869591-B2 | Paramagnetic particles that provide improved relaxivity | BARNES-JEWISH HOSPITAL (US) | 2005-03-22 | — | — | US | disclosed |
| EP-1487334-A1 | PARAMAGNETIC PARTICLES THAT PROVIDE IMPROVED RELAXIVITY | Barnes-Jewish Hospital (US) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003082105-A1 | PARAMAGNETIC PARTICLES THAT PROVIDE IMPROVED RELAXIVITY | BARNES-JEWISH HOSPITAL (US) | 2003-10-09 | — | — | WO | disclosed |
| US-20030185760-A1 | Paramagnetic particles that provide improved relaxivity | KEREOS, INC. | 2003-10-02 | — | — | US | disclosed |
| EP-0794801-A1 | PARAMAGNETIC COMPLEXES OF N-ALKYL-N-HYDROXYLAMIDES OF ORGANIC ACIDS AND EMULSIONS CONTAINING SAME FOR MAGNETIC RESONANCE IMAGING (MRI) | HEMAGEN/PFC (US) | 1997-09-17 | — | — | EP | disclosed |
| US-5614170-A | CONTRAST AGENTS OF DIETHYLENETRIAMINEPENTAACETIC ACID CHELATE COMPOUNDS | HEMAGEN/PFC (US) | 1997-03-25 | — | — | US | disclosed |
| US-5571498-A | Emulsions of paramagnetic contrast agents for magnetic resonance imaging (MRI). | HEMAGEN/PFC (US) | 1996-11-05 | — | — | US | disclosed |
| WO-1996016679-A1 | PARAMAGNETIC COMPLEXES OF N-ALKYL-N-HYDROXYLAMIDES OF ORGANIC ACIDS AND EMULSIONS CONTAINING SAME FOR MAGNETIC RESONANCE IMAGING (MRI) | HEMAGEN/PFC (US) | 1996-06-06 | — | — | WO | disclosed |
| WO-1995033494-A1 | EMULSIONS OF PARAMAGNETIC CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING (MRI), CONTAINING AN ORGANIC CHELATOR HAVING AN UNSATURATED ALIPHATIC GROUP | HEMAGEN/PFC (US) | 1995-12-14 | — | — | WO | disclosed |
| WO-1993018748-A1 | COMPOSITIONS COMPRISING A DRUG DELIVERY VEHICLE SUSPENDED IN A NONAQUEOUS FLUORINATED LIQUID | ALLERGAN, INC. (US) | 1993-09-30 | — | — | WO | disclosed |
| WO-1992021688-A1 | NEW PERFLUOROALKYLATED AMPHIPHILIC PHOSPHORUS COMPOUNDS: PREPARATION AND BIOMEDICAL APPLICATIONS | S.A. A.T.T.A. APPLICATIONS ET TRANSFERTS DE TECHN OLOGIES AVANCEES (FR) | 1992-12-10 | — | — | WO | disclosed |
| EP-0089815-A1 | Liquid perfluorocarbons, for use in ocular therapy, and preparations containing them | Haidt, Sterling Joel (US) | 1983-09-28 | — | — | EP | disclosed |